104 related articles for article (PubMed ID: 38948068)
1. Metronomic chemotherapy in cancer treatment: new wine in an old bottle.
Wu HL; Zhou HX; Chen LM; Wang SS
Theranostics; 2024; 14(9):3548-3564. PubMed ID: 38948068
[TBL] [Abstract][Full Text] [Related]
2. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
3. Metronomic chemotherapy for cancer treatment: a decade of clinical studies.
Romiti A; Cox MC; Sarcina I; Di Rocco R; D'Antonio C; Barucca V; Marchetti P
Cancer Chemother Pharmacol; 2013 Jul; 72(1):13-33. PubMed ID: 23475105
[TBL] [Abstract][Full Text] [Related]
4. The potential clinical promise of 'multimodality' metronomic chemotherapy revealed by preclinical studies of metastatic disease.
Kerbel RS; Shaked Y
Cancer Lett; 2017 Aug; 400():293-304. PubMed ID: 28202353
[TBL] [Abstract][Full Text] [Related]
5. Metronomic chemotherapy for advanced breast cancer patients.
Cazzaniga ME; Dionisio MR; Riva F
Cancer Lett; 2017 Aug; 400():252-258. PubMed ID: 28017894
[TBL] [Abstract][Full Text] [Related]
6. Metronomic Maintenance for High-Risk Pediatric Malignancies: One Size Will Not Fit All.
André N; Orbach D; Pasquier E
Trends Cancer; 2020 Oct; 6(10):819-828. PubMed ID: 32601045
[TBL] [Abstract][Full Text] [Related]
7. Metronomics: towards personalized chemotherapy?
André N; Carré M; Pasquier E
Nat Rev Clin Oncol; 2014 Jul; 11(7):413-31. PubMed ID: 24913374
[TBL] [Abstract][Full Text] [Related]
8. Rationale for the use of metronomic chemotherapy in gastrointestinal cancer.
Filippi R; Lombardi P; Depetris I; Fenocchio E; Quarà V; Chilà G; Aglietta M; Leone F
Expert Opin Pharmacother; 2018 Sep; 19(13):1451-1463. PubMed ID: 30161003
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect.
Bocci G; Kerbel RS
Nat Rev Clin Oncol; 2016 Nov; 13(11):659-673. PubMed ID: 27184418
[TBL] [Abstract][Full Text] [Related]
10. Metronomic chemotherapy and nanocarrier platforms.
Abu Lila AS; Ishida T
Cancer Lett; 2017 Aug; 400():232-242. PubMed ID: 27838415
[TBL] [Abstract][Full Text] [Related]
11. Metronomic chemotherapy in metastatic colorectal cancer.
Woo IS; Jung YH
Cancer Lett; 2017 Aug; 400():319-324. PubMed ID: 28274890
[TBL] [Abstract][Full Text] [Related]
12. Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer.
Di Desidero T; Xu P; Man S; Bocci G; Kerbel RS
Oncotarget; 2015 Dec; 6(40):42396-410. PubMed ID: 26623560
[TBL] [Abstract][Full Text] [Related]
13. A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.
Pietras K; Hanahan D
J Clin Oncol; 2005 Feb; 23(5):939-52. PubMed ID: 15557593
[TBL] [Abstract][Full Text] [Related]
14. Metronomic chemotherapy: new rationale for new directions.
Pasquier E; Kavallaris M; André N
Nat Rev Clin Oncol; 2010 Aug; 7(8):455-65. PubMed ID: 20531380
[TBL] [Abstract][Full Text] [Related]
15. Metronomic chemotherapy: Back to the future!
André N; Padovani L; Verschuur A
Drug News Perspect; 2010 Mar; 23(2):143-51. PubMed ID: 20369080
[TBL] [Abstract][Full Text] [Related]
16. Metronomic chemotherapy in combination with antiangiogenic treatment induces mosaic vascular reduction and tumor growth inhibition in hepatocellular carcinoma xenografts.
Zhou F; Hu J; Shao JH; Zou SB; Shen SL; Luo ZQ
J Cancer Res Clin Oncol; 2012 Nov; 138(11):1879-90. PubMed ID: 22736027
[TBL] [Abstract][Full Text] [Related]
17. Tumor endothelial cells as a potential target of metronomic chemotherapy.
Kim JY; Kim YM
Arch Pharm Res; 2019 Jan; 42(1):1-13. PubMed ID: 30604201
[TBL] [Abstract][Full Text] [Related]
18. Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy.
Schättler H; Ledzewicz U; Amini B
J Math Biol; 2016 Apr; 72(5):1255-80. PubMed ID: 26089097
[TBL] [Abstract][Full Text] [Related]
19. Resistance to metronomic chemotherapy and ways to overcome it.
Riesco-Martinez M; Parra K; Saluja R; Francia G; Emmenegger U
Cancer Lett; 2017 Aug; 400():311-318. PubMed ID: 28259819
[TBL] [Abstract][Full Text] [Related]
20. Clinical overview of metronomic chemotherapy in breast cancer.
Munzone E; Colleoni M
Nat Rev Clin Oncol; 2015 Nov; 12(11):631-44. PubMed ID: 26241939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
